Open Access

Effects of progressive muscular relaxation and stretching exercises combination on blood pressure among farmers in rural areas of Indonesia: a randomized study


Cite

Figure 1

PMR from Bernstein and Borkovec for tension release in 16 major muscle groups. PMR, progressive muscle relaxation.
PMR from Bernstein and Borkovec for tension release in 16 major muscle groups. PMR, progressive muscle relaxation.

Figure 2

CONSORT Flow Diagram for enrollment, allocation, and follow-up study participant. PMR, progressive muscle relaxation; SE, stretching exercise..
CONSORT Flow Diagram for enrollment, allocation, and follow-up study participant. PMR, progressive muscle relaxation; SE, stretching exercise..

Baseline characteristics of participant and BP (n = 130).

Variable Total Control (n = 65) Intervention (n = 65) Z/χ2 P-value
Age (year)
  Md (P25–P75) 45 (40.7–50.0) 46 (39.5–56.0) 45 (41.0–48.0) −1.149 0.250
Gender n (%)
  Male 107 (82.3) 49 (75.4) 58 (89.2) 3.381 0.066
  Female 23 (17.7) 16 (24.6) 7 (10.8)
Education level n (%)
  Not attending 17 (13.1) 11 (16.9) 6 (9.2) 1.787 0.618
  Elementary school 93 (71.5) 45 (69.2) 48 (73.8)
  Junior high school 13 (10.0) 6 (9.2) 7 (10.8)
  Senior high school 7 (5.4) 3 (4.6) 4 (6.2)
Smoking n (%)
  No 89 (68.5) 39 (60.0) 50 (76.9) 3.563 0.059
  Yes 41 (31.5) 26 (40.0) 15 (23.1)
Length of working per day (h)
  Md (P25–P75) 6.0 (5.0–7.0) 6.0 (5.0–8.0) 6.0 (4.0–7.0) −1.304 0.192
Length of rest in working (h)
  Md (P25–P75) 2.0 (2.0–3.0) 2.0 (2.0–3.5) 2.0 (1.0–3.0) −1.767 0.077
Length of sleeping per day (h)
  Md (P25–P75) 6.0 (5.0–7.0) 6.0 (5.0–8.0) 6.0 (5.0–7.0) −1.459 0.145
SBP (mmHg)
  Md (P25–P75) 130 (120–140) 130 (120.0–142.5) 130 (120–140) −0.939 0.348
DBP (mmHg)
  Md (P25–P75) 80 (80–90) 80 (80–90) 90 (80–90) −1.914 0.056

Distribution of number BP values among drop out of participant in control and intervention group.

BP Control (n = 35) Intervention (n = 5)


Systolic, n (%) Diastolic, n (%) Systolic, n (%) Diastolic, n (%)
Normal 4 (11.4) 35 (100.0) 0 5 (100.0)
Pre hypertension 18 (51.4) 0 4 (80.0) 0
Hypertension stage I 13 (37.1) 0 1 (20.0) 0
Hypertension stage II 0 0 0 0

The comparison of number of type BP baseline and 3 months data in the intervention group (n = 60).

Baseline SBP DBP


Baseline (n) 3 months (n) Changing (%) χ2 (P-value) Baseline (n) 3 months (n) Changing (%) χ2 (P-value)
Normal 10 16 +10.0 43.2 9 15 +10.0 34.7
Pre hypertension 24 36 +20.0 (<0.001) 19 38 +31.6 (<0.001)
Hypertension stage I 26 8 –30.0 32 7 –41.6
Hypertension stage II 0 0 0 0 0 0

Comparison of SBP and DBP baseline and 3 months data in control and intervention groups (n = 90).

Variable Control (n = 30) Intervention (n = 60)


Md (P25–P75) Z P-value Md (P25–P75) Z P-value
SBP (mmHg)
  Pre 120.0 (110.0–150.0) −1.732 0.083 130.0 (120.0–147.5) −5.381 <0.001*
  Post 120.0 (110.0–150.0) 120.0 (110.0–130.0)
DBP (mmHg)
  Pre 80.0 (80.0–90.0) −1.342 0.180 90.0 (80.0–90.0) −5.038 <0.001*
  Post 80.0 (80.0–85.0) 80.0 (76.25–83.75)

The comparison of number of type BP baseline and 3 months data in the control group (n = 30).

BP SBP DBP


Baseline (n) 3 months (n) Changing (%) χ2 (P-value) Baseline (n) 3 months (n) Changing (%) χ2 (P-value)
Normal 10 10 0 60.0 6 6 0 50.0
Pre hypertension 10 10 0 (<0.001) 16 18 + 6.7 (<0.001)
Hypertension stage I 10 10 0 8 6 –6.7
Hypertension stage II 0 0 0 0 0 0
eISSN:
2544-8994
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing